Roche sued Natco in early 2024 after learning that the Hyderabad-based company plans to launch a lower-cost generic version ...
Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback